Literature DB >> 31331487

Advances in HER2 testing.

Yun Chen1, Liang Liu2, Ronghua Ni2, Weixian Zhou2.   

Abstract

HER2-positive breast cancer is a particularly aggressive type of breast cancer. Indication of HER2 positivity is essential for its treatment. In addition to a few FDA-approved methods such as immunohistochemical (IHC) detection of HER2 protein expression and in situ hybridization (ISH) assessment of HER2 gene amplification, several novel methods have been developed for HER2 testing in recent years. This chapter provides an overview of HER2 testing with emphasis on those new methods.
© 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breast cancer; FISH; Gene; HER2 testing; IHC; Methods in development; Protein

Mesh：

Substances：

Year:  2019        PMID： 31331487     DOI： 10.1016/bs.acc.2019.03.004

Source DB:  PubMed          Journal:  Adv Clin Chem        ISSN： 0065-2423            Impact factor:   5.394


  4 in total

1.  Comparison of Her2/Neu Oncoprotein in Serum and Tissue Samples in Women with Breast Cancer.

Authors:  Rakesh Pokhrel; Binod Kumar Yadav; Nisha Sharma; Vijay Kumar Sharma; Eans Tara Tuladhar; Mithileshwor Raut; Aseem Bhattarai; Raju Kumar Dubey; Apeksha Niraula; Akash Mishra; Uttam Budhathoki
Journal:  Asian Pac J Cancer Prev       Date:  2022-02-01

2.  Lentiviral vector-based xenograft tumors as candidate reference materials for detection of HER2-low breast cancer.

Authors:  Yali Wei; Xu An; Qinmei Cao; Nanying Che; Yuanyuan Xue; Haiteng Deng; Qingtao Wang; Rui Zhou
Journal:  Front Oncol       Date:  2022-08-16       Impact factor: 5.738

3.  A photocleavable peptide-tagged mass probe for chemical mapping of epidermal growth factor receptor 2 (HER2) in human cancer cells.

Authors:  Liang Liu; Yuqiong Kuang; Zhongcheng Wang; Yun Chen
Journal:  Chem Sci       Date:  2020-09-30       Impact factor: 9.825

4.  RNA Sequencing in Comparison to Immunohistochemistry for Measuring Cancer Biomarkers in Breast Cancer and Lung Cancer Specimens.

Authors:  Maxim Sorokin; Kirill Ignatev; Elena Poddubskaya; Uliana Vladimirova; Nurshat Gaifullin; Dmitriy Lantsov; Andrew Garazha; Daria Allina; Maria Suntsova; Victoria Barbara; Anton Buzdin
Journal:  Biomedicines       Date:  2020-05-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.